Keyphrases
Lymphoma Patients
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Hematotoxicity
100%
Involved Field Radiation
100%
Radiotherapy
60%
Malignant Lymphoma
60%
Irradiation
40%
Solid Tumors
40%
Non-Hodgkin Lymphoma
40%
Radiation Effects
40%
Cytopenia
40%
Bone Marrow Toxicity
40%
Chemotherapy
20%
High Risk
20%
Breast Cancer
20%
Cancer Patients
20%
In Cancer
20%
Neutropenia
20%
Anemia
20%
Breast Cancer Susceptibility Gene 1 (BRCA1)
20%
Wilms Tumor
20%
Hodgkin Disease
20%
Marrow
20%
Platelets
20%
Thrombocytopenia
20%
Patients with Breast Cancer
20%
Granulocytes
20%
Protective Behavior
20%
Erythropoietin
20%
Breast Tumor
20%
Hematopoietic Growth Factors
20%
Red Blood Cell Transfusion
20%
Ewing Sarcoma
20%
Aplasia
20%
Bacterial Sepsis
20%
Granulocyte-monocyte Colony-stimulating Factor
20%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Lymphoma
100%
Nonhodgkin Lymphoma
66%
Solid Malignant Neoplasm
66%
Cytopenia
66%
Bone Marrow Toxicity
66%
Malignant Neoplasm
33%
Chemotherapy
33%
Anemia
33%
Nephroblastoma
33%
Sepsis
33%
Neutropenia
33%
Thrombocytopenia
33%
Erythropoietin
33%
Ewing Sarcoma
33%
Aplasia
33%
Hodgkin Disease
33%
Hemopoietic Growth Factor
33%
Colony Stimulating Factor
33%
Medicine and Dentistry
Autologous Stem Cell Transplantation
100%
Radiation Therapy
60%
Breast Cancer
60%
Lymphoma
60%
Solid Malignant Neoplasm
40%
Non-Hodgkin Lymphoma
40%
Granulocyte
40%
Bone Marrow Toxicity
40%
Cytopenia
40%
Malignant Neoplasm
20%
Neutropenia
20%
Anemia
20%
Wilms' Tumor
20%
Hodgkin's Lymphoma
20%
Sepsis
20%
Platelet
20%
Thrombocytopenia
20%
Monocyte
20%
Erythrocyte Transfusion
20%
Erythropoietin
20%
Ewing Sarcoma
20%
Aplasia
20%
Hemopoietic Growth Factor
20%
Colony Stimulating Factor
20%